Build on strength,create synergies and capture emerging science.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Build on strength,create synergies and capture emerging science.
Released on: June 05, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    'We understand the need for change in order to be able to grasp the next wave of medical innovation'.
  • Summary
  • Transcript
  • Participants
  • Company
'We understand the need for change in order to be able to grasp the next wave of medical innovation'. Dr Michel Pairet, Senior Corporate Vice President of Research and Non-clinical Development at Boehringer Ingelheim explains their new R& D strategy to PharmaVentures' Dr Fintan Walton
'We understand the need for change in order to be able to grasp the next wave of medical innovation'. Dr Michel Pairet, Senior Corporate Vice President of Research and Non-clinical Development at Boehringer Ingelheim explains their new R& D strategy to PharmaVentures' Dr Fintan Walton
'We understand the need for change in order to be able to grasp the next wave of medical innovation'. Dr Michel Pairet, Senior Corporate Vice President of Research and Non-clinical Development at Boehringer Ingelheim explains their new R& D strategy to PharmaVentures' Dr Fintan Walton
Boehringer Ingelheim
Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company's largest division, accounting for about 96% of sales. This includes prescription medicines and consumer healthcare products.